Aditi Sen shares new data from the Health Care Cost Institute on health care spending, utilization and average price trends in the employer-sponsored insurance market.
Cost of Care
Posted inCost of Care
What Happens When Price Transparency Meets Childbirth?
Jamie Daw looks at new research showing the uptake of a hospital price transparency tool for childbirth and its associations with cost of care.
Posted inCost of Care
What Happens When Urgent Care Comes to Town?
Bapu Jena digs into research looking at what happens to Medicare spending when urgent care centers enter a market.
Posted inCost of Care
The Aducanumab Aftermath: The Industry
How is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug?
Posted inCost of Care
The Aducanumab Aftermath: The Payer
A costly new Alzheimer’s drug could wreak financial havoc on insurers, seniors and taxpayers.
Posted inCost of Care
The Aducanumab Aftermath: The Doctor
One doctor grapples with questions about a controversial new Alzheimer’s drug’s safety and efficacy.
Posted inPublic Health
Babies, Boats & Abstracts: An Insider’s Guide to Health Policy Conferences
Health economist Kosali Simon shares conference tips, stories and abstracts she’s excited for at AcademyHealth and ASHEcon.
Posted inCost of Care
The FDA’s Pressure-Packed Alzheimer’s Drug Decision
The FDA weighs whether to approve a controversial new Alzheimer’s drug.
Posted inCost of Care
A Clearer Image of the Impact of Hospitals Buying Physician Practices
Ishani Ganguli on two new studies that use the number of imaging tests doctors order to understand the impact of hospitals buying physician practices.
Posted inCost of Care
Preventing HIV Just Got A Lot Cheaper. What Took So Long?
After nearly a decade of sky-high prices, new generics have sent the price of the HIV prevention drug PrEP plummeting.